MIZIP Activators

MIZIP activators are compounds that modulate the GPR24/MCH-R1 signaling pathway, potentially leading to the indirect activation of MIZIP. This class includes both peptide and non-peptide molecules, with some acting as agonists and others as antagonists. Agonists like MCH and its analogs directly stimulate GPR24, triggering intracellular signaling cascades that could involve MIZIP. Non-peptide agonists such as ATC0065 and ATC0175 offer advantages like oral bioavailability and stability, potentially impacting the MIZIP regulatory function within the GPR24 pathway.

Conversely, antagonists like SNAP-7941 and GW803430 could lead to a compensatory upregulation of GPR24 signaling. This rebound effect can enhance the receptor's activity, which in turn might augment the role of MIZIP in the receptor's signaling pathway. The use of antagonists to activate a pathway indirectly is a nuanced approach that relies on the body's response to sustained receptor inhibition, such as receptor upregulation or increased endogenous ligand production, which may in turn increase MIZIP activity.